LBX PHARMACY CHAIN |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.12 CNY | +0.69% |
|
+0.97% | +7.46% |
| Sales 2023 * | 23.4B 3.23B 269B | Sales 2024 * | 28.25B 3.9B 325B | Capitalization | 18.79B 2.59B 216B |
|---|---|---|---|---|---|
| Net income 2023 * | 929M 128M 10.69B | Net income 2024 * | 1.15B 158M 13.21B | EV / Sales 2023 * | 0.89 x |
| Net Debt 2023 * | 2.12B 292M 24.36B | Net Debt 2024 * | 1.86B 256M 21.38B | EV / Sales 2024 * | 0.73 x |
| P/E ratio 2023 * |
20.2
x | P/E ratio 2024 * |
16.4
x | Employees | - |
| Yield 2023 * |
1.52% | Yield 2024 * |
1.83% | Free-Float | 46.61% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | +0.69% | ||
| 1 week | +0.97% | ||
| Current month | +7.10% | ||
| 1 month | +12.98% | ||
| 3 months | +11.99% | ||
| 6 months | +27.66% | ||
| Current year | +7.46% |
1 week
31.61
32.85
1 month
29.3132.85
Current year
26.1633.48
1 year
22.8136.08
3 years
21.4946.62
5 years
21.4971.62
10 years
10.8271.62
| Managers | Title | Age | Since |
|---|---|---|---|
Li Wang
DFI | Director of Finance/CFO | 42 | - |
Xia Er Liu
IRC | Investor Relations Contact | - | - |
Shi Ni Feng
SEC | Corporate Secretary | 39 | 09/19/09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Chuan Ren
BRD | Director/Board Member | 64 | 22/02 |
Zi Qi Xie
BRD | Director/Board Member | 47 | 02/22/02 |
Zi Long Xie
FOU | Founder | 57 | 01/05/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 32.12 | +0.69% | 3,393,073 |
| 25/24/25 | 31.9 | -0.19% | 1,800,089 |
| 24/24/24 | 31.96 | -1.51% | 3,534,085 |
| 23/24/23 | 32.45 | +0.25% | 2,601,345 |
| 22/24/22 | 32.37 | +1.76% | 3,037,254 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.
Sector
Drug Retailers
Calendar
30/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
32.12
CNY
Average target price
38.63
CNY
Spread / Average Target
+20.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.46% | 2.59B | |
| -11.64% | 3.62B | |
| -0.09% | 3.36B | |
| -23.44% | 3.06B | |
| -9.26% | 1.75B | |
| +9.30% | 1.35B | |
| -20.60% | 957M | |
| -38.42% | 704M | |
| -0.53% | 450M | |
| -1.85% | 370M |
- Stock Market
- Equities
- 603883 Stock
